Intranasal delivery of interferon-β-loaded nanoparticles induces control of neuroinflammation in a preclinical model of multiple sclerosis: A promising simple, effective, non-invasive, and low-cost therapy

Intranasal delivery of interferon-β-loaded nanoparticles induces control of neuroinflammation in a preclinical model of multiple sclerosis: A promising simple, effective, non-invasive, and low-cost therapy

Autores: Luis F González, Eric Acuña, Gabriel Arellano, Paola Morales, Paula Sotomayor, Felipe Oyarzún-Ampuero, Rodrigo Naves.  Resumen: La esclerosis múltiple (EM) es una enfermedad autoinmune que afecta al sistema nervioso central (SNC). La molécula interferón...